Literature DB >> 1105646

Insulin antibodies and the control of diabetes.

K Dixon, P D Exon, J M Malins.   

Abstract

Seventy-two insulin-treated diabetic patients were classified on the basis of a clinical evaluation of their control of diabetes. There were 39 stable patients, 23 unstable patients and 10 patients of intermediate degree of control. Four insulin resistant patients were also studied. Serum insulin antibodies were measured in each patient and the concept of insulin buffering by its antibody was developed. Most unstable patients had low concentrations of insulin antibody. Twenty-four of the 39 stable patients had a significant concentration of insulin antibody and 15 patients had low levels of antibody. The insulin resistant patients had hugh levels of antibody. All unstable patients had low antibody buffering and all insulin resistant patients had high antibody buffering. Although many stable patients had buffering antibodies others lacking antibody required a low insulin dose and their stability of diabetic control was attributed to residual pancreatic function.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1105646

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  21 in total

1.  Editorial: control of diabetes and insulin antibodies.

Authors: 
Journal:  Br Med J       Date:  1976-02-28

2.  Modern management of the insulin dependent diabetic.

Authors:  R Tattersall
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

3.  The newer insulins.

Authors:  J G Devlin; O Maguire; V Parameswaran
Journal:  Ir J Med Sci       Date:  1979       Impact factor: 1.568

4.  Twenty-four hour profiles of plasma C-peptide in type 1 (insulin-dependent) diabetic children.

Authors:  G A Werther; R C Turner; P A Jenkins; J D Baum
Journal:  Diabetologia       Date:  1982-04       Impact factor: 10.122

Review 5.  Circulating insulin-binding antibodies.

Authors:  A B Kurtz; J D Nabarro
Journal:  Diabetologia       Date:  1980-10       Impact factor: 10.122

6.  Highly purified insulins.

Authors:  K G Alberti; M Nattrass
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  Soluble immune complexes in the sera of newly diagnosed insulin-dependent diabetics and in treated diabetics.

Authors:  W J Irvine; S F Al-Khateeb; U Di Mario; C M Feek; R S Gray; B Edmond; L J Duncan
Journal:  Clin Exp Immunol       Date:  1977-10       Impact factor: 4.330

8.  Human insulin-specific immunoglobulin G antibody and hypoglycemic attacks after the injection of gold thioglucose.

Authors:  K Yao; Y Uchigata; H Kyono; H Yokoyama; Y Eguchi; H Fukushima; K Yamauchi; Y Hirata
Journal:  J Endocrinol Invest       Date:  1992-01       Impact factor: 4.256

9.  Insulin antibodies and hypoglycemia in diabetic patients. Can a quantitative analysis of antibody binding predict the risk of hypoglycemia?

Authors:  M R Kim; L R Sheeler; N Mansharamani; M T Haug; C Faiman; M K Gupta
Journal:  Endocrine       Date:  1997-06       Impact factor: 3.633

Review 10.  Methods of assessing diabetic control.

Authors:  G D Molnar; G J Marien; A N Hunter; C H Harley
Journal:  Diabetologia       Date:  1979-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.